Product Information
FONDAPARINUX 7.5 MG/0.6 ML SYR is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $42.7121 per ML under NDC 70710151606. Its NADAC has been published 244 times since Feb 17, 2021.
FDA first approved this application on Nov 14, 2018. Its Orange Book therapeutic-equivalence code is AP.
Strength
7.5 mg/.6mL
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710151606
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
FONDAPARINUX SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA208615FDA Approved
11/14/2018
TE Code
AP
On Market Since
2/6/2019
Pharmacological Classes
Price Statistics
The NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has been published 244 times since Feb 17, 2021, and over the history we have for it it has declined 37.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $42.7121 per ML |
|---|---|
| All-time high | $68.7043 (Dec 15, 2021) |
| All-time low | $34.9283 (Jun 19, 2024) |
| 52-week high | $43.4533 |
| 52-week low | $38.5660 |
| Median price | $49.6397 |
| Average price | $51.0433 |
| Largest weekly change | +27.9% (Jul 17, 2024) |
| Weeks tracked | 244 |
| Tracking since | Feb 17, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FONDAPARINUX 7.5 MG/0.6 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 7.5 MG/0.6 ML SYR, manufactured by Zydus Pharmaceuticals (USA) Inc., is $42.7121 per ML (NDC 70710151606), effective Aug 19, 2026.
How has the price of FONDAPARINUX 7.5 MG/0.6 ML SYR changed over time?
Over the history we have for it, the NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has declined 37.0%. It has been tracked across 244 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for FONDAPARINUX 7.5 MG/0.6 ML SYR?
Since Feb 17, 2021, the NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has ranged from a low of $34.9283 (Jun 19, 2024) to a high of $68.7043 (Dec 15, 2021), with a median of $49.6397 per ML.
Are there cheaper alternatives to FONDAPARINUX 7.5 MG/0.6 ML SYR?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FONDAPARINUX 7.5 MG/0.6 ML SYR, is $20.9233 per ML — about 51% below FONDAPARINUX 7.5 MG/0.6 ML SYR.
Who manufactures FONDAPARINUX 7.5 MG/0.6 ML SYR?
FONDAPARINUX 7.5 MG/0.6 ML SYR (NDC 70710151606) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.